|
⚲
|
| Endocyte Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001235007 |
| Sale | 2009-08-03 ($30.0 M Offered, $26.6 M Sold) |
| Fund | |
| Phone | 7654637175 |
| Address | 3000 Kent Ave Ste A1100 West Lafayette, 47906 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Fred Middleton | |
| Ann Hanham | |
| John Aplin | |
| Philip Low | |
| Douglas Bailey | |
| P Ron Ellis | |
| Mike Sherman | |
| Keith Brauer | |
| Jack Clawson |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
ASQI Emerging Markets Fund, LP
✚
|
0.0 | |
|
Assadi Hamideh
✚
|
0.0 | |
|
Asset Resurgence Mauritius Fund
✚
|
0.0 | |
|
Assure, a Series of Jason's Syndicate, LLC
✚
|
0.0 | |
|
Astea International Inc
✚
|
0.0 | |
|
Astignes Asia Rates Compass Fund Ltd.
✚
|
0.0 | |
|
AST & Science, LLC
✚
|
0.0 | |
|
Asymmetria Investors II, LLC - Series 2
✚
|
0.0 | |
|
Asymmetria Investors II, LLC - Series 3
✚
|
0.0 | |
|
Aspire Ventures Precision Medicine Fund, LLC
✚
|
0.0 |